Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma, Ewing × Diphosphonates × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 3 Breast Neoplasms 2 Sarcoma, Ewing 1 Osteoporotic Fractures 1 Osteoporosis 1 Neoplasms 1 Musculoskeletal Pain 1 Multiple Myeloma 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Arthralgia 1

Interventions

Cyclophosphamide 24 Temozolomide 21 Irinotecan 18 Vincristine 17 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 cabozantinib 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Drug Therapy 5 regorafenib 4 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Phantoms, Imaging 4 Nivolumab 4 Gemcitabine 4 olaparib 3 irinotecan sucrosofate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡